Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naldemedine for opioid-induced bowel dysfunction in healthy opioid-naive adults
2023-507744-36-00Phase 2Completed
- Sponsor
- Aalborg University Hospital
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in opioid-induced bowel dysfunction (OIBD) comparing Tramadol + naldemedine with Tramadol + placebo (2 arms). Primary endpoints: Total gastrointestinal transit time and Colorectal transit time. Started Mar 2024; status: completed.
02
Drugs
naldemedinetramadol
03
Conditions
opioid-induced bowel dysfunction (OIBD)
Beyond the preview
Go deeper on 2023-507744-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507744-36-00.